Acrow India

Nashik, India Founded: 1960 • Age: 66 yrs Listed
Inpatient and outpatient healthcare services are provided in multiple locations.

About Acrow India

Acrow India is a publicly listed company based in Nashik (India) founded in 1960. Inpatient and outpatient healthcare services are provided in multiple locations. The company has 2 employees. Its Indian entity Acrow India Limited reported revenue of β‚Ή11.57 Cr. Acrow India offers products and services including Cotton Yarns and Cotton Processing.

Company details

Acrow India was founded in 1960 and is headquartered in Nashik, India, within the healthcare sector. Inpatient and outpatient services are delivered across specialties including cardiology, oncology, and orthopedics. Diagnostic imaging, emergency care, and therapeutic treatments are offered, alongside support such as patient billing and financial assistance. Clinics are operated in various locations, with programs addressing conditions like diabetes management. Community health initiatives are also emphasized.

  • Headquarters Nashik, India
  • Employees 2
  • Stage Public
  • Website acrowindia.com
  • Legal Name Acrow India Limited
Key Metrics
  • Market Cap
    ₹57.73 Cr

    ACROW · BSE

  • Share Price
    ₹937.00

    +3.88% today

  • Revenue
    ₹9.97 Cr

    FY 2025-26 · +207.7% YoY

  • EBITDA
    −₹0.77 Cr

    Margin -7.7%

  • Net Profit
    ₹0.44 Cr

    FY 2025-26 · +229.4% YoY

  • P/E (TTM)
    110.7x

    P/B 2.5x

  • Employee Count
    2

Products & Services of Acrow India

Acrow India offers a comprehensive portfolio of products and services, including Cotton Yarns and Cotton Processing.

Cotton Yarns
Manufacturing Products

Cotton yarns are manufactured and supplied for industrial applications

Cotton Processing
Agricultural Services

Cotton is processed and traded as part of agricultural activities

Board of directors of Acrow India Limited (Acrow India)

Acrow India Limited is the primary company behind Acrow India. The board of Acrow India Limited currently have 6 directors; the longest-serving is Gopal Agrawal, appointed in 2022. 16 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Gopal Agrawal
DIN 02160569
Managing Director19 Dec 20223 yrs 10 moAcrow India Limited
Shyam Agrawal
DIN 02192098
Whole-time director19 Dec 20223 yrs 10 moAcrow India Limited
Devinder Khurana
DIN 00059707
Director19 Dec 20223 yrs 10 moAcrow India Limited
Kashinath Ganapaty Iyer
DIN 01195975
Director19 Dec 20223 yrs 10 moAcrow India Limited
Sarika Abhijit Kulkarni
DIN 07141926
Director19 Dec 20223 yrs 10 moAcrow India Limited
Sanjay Trilokchand Agrawal
DIN 03500067
Whole-time director22 May 20233 yrs 5 moAcrow India Limited

IPO & Listings of Acrow India

Acrow India is a publicly listed company on the BSE with ticker symbol ACROW in India, operating in the Producer manufacturing sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date10 Sep 2001
  • Listed onBSE: 513149
  • Listed entityAcrow India Limited
  • Exchange sectorProducer manufacturing
  • ISININE950D01012
  • Share price₹817.90 (-0.5% on the day) · 2026-10-14
  • Market capitalisation₹52.6 Cr
  • Price to earnings100.8
  • EPS (diluted, trailing year)₹8.11
  • Volume (last session)147

Financials of Acrow India

Exchange-reported figures of Acrow India Limited, the listed company behind Acrow India (BSE: ACROW).

Financial Highlights

FY 2025-26 Β· Standalone
Revenue
₹9.97 Cr
+207.7% YoY
EBITDA
−₹0.77 Cr
+28.0% YoY
Profit After Tax
₹0.44 Cr
+229.4% YoY
Net Worth
₹22.83 Cr
+1.9% YoY
Total Assets
₹22.83 Cr
+1.9% YoY
Total Debt
Nil

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue9.973.240.000.000.000.000.00
Revenue growth+207.7%------
EBITDA(0.77)(1.07)(1.90)(0.97)(1.43)(0.69)(0.91)
EBITDA margin-7.7%-33.0%-----
Profit before tax0.601.180.61(0.04)1.11(0.33)(0.25)
Net profit0.44(0.34)0.94(0.32)(0.83)(0.38)(0.20)
Net profit margin+4.4%-10.5%-----
EPS (β‚Ή)6.73(13.76)16.010.2913.44(2.18)(4.71)
Balance sheet
Total assets22.8322.4023.2822.2522.2521.3721.51
Net worth22.8322.4023.2822.2522.2321.3721.51
Total debt0.000.000.000.000.000.000.00
Cash & bank0.000.070.010.037.185.765.98
Net working capital21.2220.5918.4718.089.328.237.79
Cash flow
Cash from operations(3.47)(0.78)(0.82)(1.01)(0.60)(0.64)(0.65)
Cash from investing3.410.830.80(6.14)2.020.410.79
Cash from financing0.000.000.000.000.000.00(0.05)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue0.001.057.161.750.003.240.000.00
Revenue growth (YoY)--67.6%------
Other income0.400.350.450.400.400.450.710.93
Total expenses0.121.376.952.190.233.900.200.12
EBITDA(0.12)(0.32)0.21(0.44)(0.23)(0.66)(0.20)(0.12)
EBITDA margin--30.5%+2.9%-25.1%--20.4%--
Depreciation0.060.060.060.060.060.050.070.06
Interest0.000.000.000.000.000.000.000.00
Profit before tax0.22(0.03)0.60(0.10)0.11(0.26)0.440.75
Tax0.050.000.160.000.020.010.041.90

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 15 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue0.001.057.161.750.003.240.000.00
Revenue growth (YoY)--67.6%------
Other income0.400.350.450.400.400.450.710.93
Total expenses0.121.376.952.190.233.900.200.12
EBITDA(0.12)(0.32)0.21(0.44)(0.23)(0.66)(0.20)(0.12)
EBITDA margin--30.5%+2.9%-25.1%--20.4%--
Depreciation0.060.060.060.060.060.050.070.06
Interest0.000.000.000.000.000.000.000.00
Profit before tax0.22(0.03)0.60(0.10)0.11(0.26)0.440.75
Tax0.050.000.160.000.020.010.041.90
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue9.973.240.000.000.000.000.00
Revenue growth+207.7%------
Other income1.602.502.811.112.780.600.93
Total expenses10.744.311.900.971.430.690.91
Employee cost0.000.230.110.160.230.180.07
EBITDA(0.77)(1.07)(1.90)(0.97)(1.43)(0.69)(0.91)
EBITDA margin-7.7%-33.0%-----
Depreciation0.230.250.300.180.240.240.27
Interest0.000.000.000.000.000.000.00
Profit before tax0.601.180.61(0.04)1.11(0.33)(0.25)
Tax0.162.04(0.42)(0.07)0.25(0.18)0.05
Net profit0.44(0.34)0.94(0.32)(0.83)(0.38)(0.20)
Net profit margin+4.4%-10.5%-----
EPS (β‚Ή)6.73(13.76)16.010.2913.44(2.18)(4.71)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital0.640.640.640.640.640.640.64
Reserves & surplus22.1921.7622.6421.6121.5920.7320.87
Shareholders' funds (net worth)22.8322.4023.2822.2522.2321.3721.51
Secured loans0.000.000.000.000.000.000.00
Unsecured loans0.000.000.000.000.000.000.00
Total debt0.000.000.000.000.000.000.00
Total liabilities22.8322.4023.2822.2522.2521.3721.51
Assets
Gross block5.185.587.618.499.0111.2911.29
Net block2.152.413.533.873.984.024.26
Capital work in progress0.000.000.000.000.000.000.00
Investments0.000.000.000.008.958.999.25
Inventories0.000.000.000.000.000.660.66
Sundry debtors0.093.400.000.000.150.140.04
Cash & bank balances0.000.070.010.037.185.765.98
Loans & advances21.5822.0018.9918.102.071.751.22
Total current assets21.6725.4719.0018.139.408.317.90
Total current liabilities0.454.880.530.050.080.080.11
Net working capital21.2220.5918.4718.089.328.237.79
Total assets22.8322.4023.2822.2522.2521.3721.51
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.070.010.037.185.765.985.89
Net cash from operating activities(3.47)(0.78)(0.82)(1.01)(0.60)(0.64)(0.65)
Net cash from investing activities3.410.830.80(6.14)2.020.410.79
Net cash from financing activities0.000.000.000.000.000.00(0.05)
Net change in cash(0.06)0.06(0.02)(7.15)1.42(0.23)0.09
Closing cash0.000.070.010.037.185.765.98
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+207.7%------
EBITDA growth+28.0%+43.7%-95.9%+32.2%-107.3%+24.2%-
PBT growth-49.2%+93.4%+9998.0%-+9998.0%-32.0%-
Net income growth+229.4%-136.2%+393.8%+61.5%-118.4%-90.0%-
Revenue CAGR (3Y)-------100.0%
EBITDA CAGR (3Y)-7.4%-9.2%+40.2%+2.2%+26.9%-14.7%-7.5%
Profitability & leverage
Net income margin+4.4%-26.5%-----
Return on capital employed-+2.1%+2.0%-1.8%-3.8%-2.6%-0.7%
Return on net worth--1.6%+4.1%-1.5%-3.8%-1.7%-0.9%
Debt / equity-0.000.000.000.000.000.00
Long-term debt / equity-0.000.000.000.000.000.00
Interest cover0.000.000.000.000.000.000.00
Efficiency & per share
Fixed asset turnover-0.490.000.000.000.000.00
Inventory turnover-0.000.000.000.000.000.00
Debtors turnover-1.910.000.000.000.000.00
EPS (β‚Ή)6.73(13.76)16.010.2913.44(2.18)(4.71)
Dividend per share (β‚Ή)0.000.000.000.000.000.000.00
Book value per share (β‚Ή)0.00349.94363.70347.70347.41333.97336.16

Web traffic of Acrow India

The website of Acrow India (acrowindia.com) receives about 1.2K visits a month.

  • Monthly visits
    1.2K

    ▲ 48.7% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Acrow India

Acrow India was founded in 1960.

Acrow India is headquartered in Nashik, India. It is registered at Nashik, Maharashtra, India.

Acrow India has 2 employees.

The primary company behind Acrow India, Acrow India Limited, reported revenue of β‚Ή11.57 Cr for FY 2026, up 208% year on year.

Acrow India was founded in 1960 and is headquartered in Nashik, India, within the healthcare sector. Inpatient and outpatient services are delivered across specialties including cardiology, oncology, and orthopedics. Diagnostic imaging, emergency care, and therapeutic treatments are offered, alongside support such as patient billing and financial assistance. Clinics are operated in various locations, with programs addressing conditions like diabetes management. Community health initiatives are also emphasized.

Acrow India offers Cotton Yarns and Cotton Processing.

Yes, Acrow India is publicly traded on BSE under the ticker symbol ACROW.

Acrow India operates through Acrow India Limited.

The legal entities of Acrow India currently have 8 directors, including Gopal Agrawal, Shyam Agrawal, Devinder Khurana and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available